LATUDA 74mg film-coated tablets medication leaflet

N05AE05 lurasidone • Nervous system | Antipsychotics | Indole derivatives

Lurasidone is an atypical antipsychotic used for the treatment of schizophrenia and depressive episodes associated with bipolar disorder. It works by regulating dopamine and serotonin activity in the brain.

The medication is taken orally, usually once daily, and should be taken with food to improve absorption. It is important to follow the doctor's instructions and not to discontinue treatment abruptly.

Side effects may include drowsiness, nausea, weight gain, or dizziness. In rare cases, severe reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur.

Lurasidone is not recommended for patients with hypersensitivity to this medication or those taking strong CYP3A4 inhibitors.

General data about LATUDA 74mg

Substance: lurasidone

Date of last drug list: 01-12-2023

Commercial code: W64572002

Concentration: 74mg

Pharmaceutical form: film-coated tablets

Quantity: 28

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ANDERSONBRECON (UK) LTD. - MAREA BRITANIE

Holder: A.C.R.A.F. S.P.A. - ITALIA

Number: 913/2014/16

Shelf life: 5 years

Concentrations available for lurasidone

18.5mg, 37mg, 74mg
PDF icon EMA leaflet
Published: 08/04/2014
Updated: 10/01/2024

Other substances similar to lurasidone